Pharmaceutical composition comprising a factor VIIA and a factor XIII

Details for Australian Patent Application No. 2001258228 (hide)

Owner Novo Nordisk Health Care AG

Inventors Petersen, Lars Christian; Rojkjaer, Rasmus; Hedner, Ulla

Agent Spruson & Ferguson

Pub. Number AU-B-2001258228

PCT Pub. Number WO01/85198

Priority PA 2000 00771 10.05.00 DK; PA 2000 00871 06.06.00 DK; PA 2000 00778 10.05.00 DK

Filing date 10 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 12 January 2006

International Classifications

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

Event Publications

10 July 2003 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pharmaceutical composition comprising a factor VIIA and a factor XIII

11 December 2003 Assignment before Grant

  Novo Nordisk A/S The application has been assigned to Novo Nordisk Health Care AG

12 January 2006 Application Accepted

  Published as AU-B-2001258228

11 May 2006 Standard Patent Sealed

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001258229

2001258227